Celsion Corporation Announces Pricing of $30 Million

LAWRENCEVILLE, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based...

Related Keywords

New York ,United States ,Switzerland ,Lawrenceville ,Celsion Gmb ,Kim Sutton Golodetz ,Exchange Commission ,Celsion Corporation ,Exchange Commission On ,Jeffreyw Church ,A Gp Alliance Global Partners ,Current Report ,United States Securities ,Alliance Global Partners ,Celsion Gmbh ,Private Securities Litigation Reform Act ,Vice President ,Sutton Golodetz ,Nasdaq Clsn ,Celsion Corp ,Na Based Immunotherapy ,Next Generation Vaccines ,Ars Cov 2 ,